{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T01:08:46Z","timestamp":1784768926539,"version":"3.55.0"},"reference-count":86,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T00:00:00Z","timestamp":1770508800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01HL151367"],"award-info":[{"award-number":["R01HL151367"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["European J of Haematology"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Anemia frequently complicates cancer care, leading to reduced quality of life and poorer overall prognosis. Even mild\u2010to\u2010moderate anemia in cancer patients has been associated with worse outcomes, including increased fatigue, physical decline, and decreased tolerance to cancer therapies. Importantly, studies have demonstrated that correcting anemia and improving hemoglobin levels can significantly alleviate fatigue, enhance emotional well\u2010being, and improve overall quality of life. An improved understanding of the underlying mechanisms of cancer\u2010related anemia has led to the development of a range of therapeutic strategies, from traditional supportive measures to innovative targeted therapies. In the following manuscript, we provide an in\u2010depth review of these approaches, beginning with established treatments and progressing to newer investigational therapies and specialized strategies for patients with solid tumors and hematologic malignancies. This framework aims to guide clinicians in selecting and tailoring anemia management to improve outcomes and quality of life for patients across cancer types.<\/jats:p>","DOI":"10.1111\/ejh.70135","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:09:57Z","timestamp":1770595797000},"page":"709-723","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Navigating Anemia in Solid and Hematologic Malignancies: A Comprehensive Review of Classical and Emerging Therapies"],"prefix":"10.1111","volume":"116","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-3770-178X","authenticated-orcid":false,"given":"Lauryn K.","family":"Bailey","sequence":"first","affiliation":[{"name":"Department of Medicine Oregon Health and Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Mahjoub","sequence":"additional","affiliation":[{"name":"School of Medicine, Oregon Health and Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7038-8889","authenticated-orcid":false,"given":"Corinne","family":"LaVasseur","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology Oregon Health and Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Berkowitz","sequence":"additional","affiliation":[{"name":"Department of Medicine Oregon Health and Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice E.","family":"Torere","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology Oregon Health and Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas V.","family":"Seifer","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology Oregon Health and Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7061-0853","authenticated-orcid":false,"given":"Aditya K.","family":"Malhotra","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology Oregon Health and Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Shatzel","sequence":"additional","affiliation":[{"name":"Division of Hematology and Medical Oncology Oregon Health and Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,2,8]]},"reference":[{"key":"e_1_2_17_2_1","unstructured":"Guideline on haemoglobin cutoffs to define anaemia in individuals and populations \u201cWHO Guidelines Approved by the Guidelines Review Committee. Geneva \u201d2024."},{"key":"e_1_2_17_3_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2011-S3-12"},{"key":"e_1_2_17_4_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2012.0064"},{"issue":"10","key":"e_1_2_17_5_1","first-page":"640","article-title":"Workup of Anemia in Cancer","volume":"18","author":"Anand S.","year":"2020","journal-title":"Clinical Advances in Hematology & Oncology"},{"key":"e_1_2_17_6_1","doi-asserted-by":"publisher","DOI":"10.3310\/hta11130"},{"key":"e_1_2_17_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-61015-4"},{"key":"e_1_2_17_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/91.19.1616"},{"key":"e_1_2_17_9_1","doi-asserted-by":"publisher","DOI":"10.36255\/exon-publications.metastasis.hematological-toxicity"},{"key":"e_1_2_17_10_1","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S89480"},{"key":"e_1_2_17_11_1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-S1-43"},{"key":"e_1_2_17_12_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0026"},{"key":"e_1_2_17_13_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-167643"},{"key":"e_1_2_17_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-10-844696"},{"key":"e_1_2_17_15_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V126.23.4559.4559"},{"key":"e_1_2_17_16_1","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2020-0582"},{"key":"e_1_2_17_17_1","doi-asserted-by":"publisher","DOI":"10.3390\/nu14224739"},{"key":"e_1_2_17_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mds338"},{"key":"e_1_2_17_19_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.R115.650150"},{"key":"e_1_2_17_20_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V120.21.5167.5167"},{"key":"e_1_2_17_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018030387"},{"key":"e_1_2_17_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23628"},{"key":"e_1_2_17_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-015-0842-3"},{"key":"e_1_2_17_24_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2023009903"},{"key":"e_1_2_17_25_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090470"},{"key":"e_1_2_17_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6605498"},{"issue":"12","key":"e_1_2_17_27_1","article-title":"Erythropoietin or Darbepoetin for Patients With Cancer","volume":"12","author":"Tonia T.","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"e_1_2_17_28_1","volume-title":"Epoetin and Darbepoetin for Managing Anemia in Patients Undergoing Cancer Treatment: Comparative Effectiveness Update","author":"Grant M. D.","year":"2013"},{"key":"e_1_2_17_29_1","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2020000127"},{"key":"e_1_2_17_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41375-018-0118-9"},{"key":"e_1_2_17_31_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.192"},{"key":"e_1_2_17_32_1","doi-asserted-by":"publisher","DOI":"10.1586\/17474086.2016.1154452"},{"key":"e_1_2_17_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05229.x"},{"key":"e_1_2_17_34_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40164-015-0021-2"},{"key":"e_1_2_17_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12846"},{"key":"e_1_2_17_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2009.01266.x"},{"key":"e_1_2_17_37_1","doi-asserted-by":"publisher","DOI":"10.1159\/000097463"},{"key":"e_1_2_17_38_1","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2022.0046"},{"key":"e_1_2_17_39_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2012.684347"},{"key":"e_1_2_17_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32328"},{"key":"e_1_2_17_41_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.117176"},{"key":"e_1_2_17_42_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08569.x"},{"key":"e_1_2_17_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-1274-6"},{"key":"e_1_2_17_44_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-02-139824"},{"key":"e_1_2_17_45_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020002725"},{"key":"e_1_2_17_46_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-99-110805"},{"key":"e_1_2_17_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(24)00203-5"},{"key":"e_1_2_17_48_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-178635"},{"key":"e_1_2_17_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)00874-7"},{"key":"e_1_2_17_50_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2024012939"},{"key":"e_1_2_17_51_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-024-02080-x"},{"key":"e_1_2_17_52_1","unstructured":"\u201cA Phase II Study Evaluating the Efficacy and Safety of Imetelstat in Patients With HR Myelodysplastic Syndromes or AML Failing HMA\u2010Based Therapy [Internet] \u201d2022 https:\/\/clinicaltrials.gov\/study\/NCT05583552."},{"key":"e_1_2_17_53_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.02864"},{"key":"e_1_2_17_54_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2022-0235"},{"key":"e_1_2_17_55_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-203800"},{"key":"e_1_2_17_56_1","unstructured":"\u201cAn Open Label Phase 1\/1b Study to Evaluate the Safety Pharmacokinetics Pharmacodynamics and Clinical Activity of Imetelstat in Combination With Ruxolitinib in Patients With Myelofibrosis [Internet] \u201d2022 https:\/\/clinicaltrials.gov\/study\/NCT05371964."},{"key":"e_1_2_17_57_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature16979"},{"key":"e_1_2_17_58_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-004572"},{"key":"e_1_2_17_59_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0165948"},{"key":"e_1_2_17_60_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1904794"},{"key":"e_1_2_17_61_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2016.06.007"},{"key":"e_1_2_17_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-07-575373"},{"key":"e_1_2_17_63_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-05-287417"},{"key":"e_1_2_17_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06937.x"},{"key":"e_1_2_17_65_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22047"},{"key":"e_1_2_17_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/1042819021000040008"},{"key":"e_1_2_17_67_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41408-017-0029-4"},{"key":"e_1_2_17_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beem.2022.101653"},{"key":"e_1_2_17_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clml.2017.11.007"},{"key":"e_1_2_17_70_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-015-2435-7"},{"key":"e_1_2_17_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)02036-0"},{"key":"e_1_2_17_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106370"},{"key":"e_1_2_17_73_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.10209"},{"issue":"4","key":"e_1_2_17_74_1","article-title":"Danazol Treatment for Thrombocytopenia in Myelodysplastic Syndromes: Can an \u201cOld\u2010Fashioned\u201d Drug Be Effective?","volume":"7","author":"Riva M.","year":"2023","journal-title":"Hema"},{"key":"e_1_2_17_75_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-017-0427-x"},{"key":"e_1_2_17_76_1","doi-asserted-by":"publisher","DOI":"10.2147\/JEP.S262349"},{"key":"e_1_2_17_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.2432"},{"key":"e_1_2_17_78_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2024-203719"},{"key":"e_1_2_17_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2019.10.004"},{"key":"e_1_2_17_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.115239"},{"key":"e_1_2_17_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-015-2929-9"},{"key":"e_1_2_17_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.26865"},{"key":"e_1_2_17_83_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-182991"},{"key":"e_1_2_17_84_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfae075"},{"key":"e_1_2_17_85_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.02742"},{"key":"e_1_2_17_86_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfae051"},{"key":"e_1_2_17_87_1","unstructured":"\u201cA Phase 3 Randomized Open\u2010Label (Sponsor\u2010Blind) Active\u2010Controlled Parallel\u2010Group Multi\u2010Center Event Driven Study in Dialysis Subjects With Anemia Associated With Chronic Kidney Disease to Evaluate the Safety and Efficacy of Daprodustat Compared to Recombinant Human Erythropoietin Following a Switch From Erythropoietin\u2010Stimulating Agents \u201d[Internet].2016 https:\/\/clinicaltrials.gov\/study\/NCT02879305."}],"container-title":["European Journal of Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.70135","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ejh.70135","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ejh.70135","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T12:04:50Z","timestamp":1777982690000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ejh.70135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,8]]},"references-count":86,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1111\/ejh.70135"],"URL":"https:\/\/doi.org\/10.1111\/ejh.70135","archive":["Portico"],"relation":{},"ISSN":["0902-4441","1600-0609"],"issn-type":[{"value":"0902-4441","type":"print"},{"value":"1600-0609","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,8]]},"assertion":[{"value":"2025-10-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-01-28","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}